Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-006559
Filing Date
2019-11-14
Accepted
2019-11-14 16:47:37
Documents
92
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 752241
2 CERTIFICATION curr_ex311.htm EX-31.1 8154
3 CERTIFICATION curr_ex312.htm EX-31.2 9061
4 CERTIFICATION curr_ex321.htm EX-32.1 3298
5 CERTIFICATION curr_ex322.htm EX-32.2 3225
12 curr_10qimg1.jpg GRAPHIC 6651
  Complete submission text file 0001477932-19-006559.txt   5976868

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20190930.xml EX-101.INS 1102476
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20190930.xsd EX-101.SCH 95180
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20190930_lab.xml EX-101.LAB 506763
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20190930_cal.xml EX-101.CAL 39185
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20190930_pre.xml EX-101.PRE 490795
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20190930_def.xml EX-101.DEF 269332
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 191221210
SIC: 2673 Plastics, Foil & Coated Paper Bags